|
KMID : 0624620230560040225
|
|
BMB Reports
2023 Volume.56 No. 4 p.225 ~ p.233
|
|
|
Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models
|
|
Kim Sang-Hwa
Lee Su-Yeon
Seo Haeng-Ran
|
|
|
Abstract
|
|
|
|
Hepatocellular carcinoma (HCC) is a very common form of cancer worldwide and is often fatal. Although the histopathology of HCC is characterized by metabolic pathophysiology, fibrosis, and cirrhosis, the focus of treatment has been on eliminating HCC. Recently, three-dimensional (3D) multicellular hepatic spheroid (MCHS) models have provided a) new therapeutic strategies for progressive fibrotic liver diseases, such as antifibrotic and anti-inflammatory drugs, b) molecular targets, and c) treatments for metabolic dysregulation. MCHS models provide a potent anti-cancer tool because they can mimic a) tumor complexity and heterogeneity, b) the 3D context of tumor cells, and c) the gradients of physiological parameters that are characteristic of tumors in vivo. However, the information provided by an multicelluar tumor spheroid (MCTS) model must always be considered in the context of tumors in vivo. This mini-review summarizes what is known about tumor HCC heterogeneity and complexity and the advances provided by MCHS models for innovations in drug development to combat liver diseases.
|
|
|
KEYWORD
|
|
|
Drug discovery, Fibrosis, Hepatocellular carcinoma, Multicellular hepatic spheroid, Three-dimensional
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|